Incidence of SARS-CoV-2 Infection in Asthma Patients on Omalizumab Therapy
Yıl: 2022 Cilt: 44 Sayı: 5 Sayfa Aralığı: 533 - 534 Metin Dili: İngilizce DOI: 10.14744/etd.2022.28938 İndeks Tarihi: 02-10-2022
Incidence of SARS-CoV-2 Infection in Asthma Patients on Omalizumab Therapy
Öz: -
Anahtar Kelime: Belge Türü: Makale Makale Türü: Editöre Mektup Erişim Türü: Erişime Açık
- 1. Tezer H, Deniz M. COVID-19: Infection control and treatment strategy in pediatric age group in Turkey. Erciyes Med J 2021; 43(2): 107–9.
- 2. Passante M, Napolitano M, Dastoli S, Bennardo L, Fabbrocini G, Nisticò SP, et al. Safety of omalizumab treatment in patients with chronic spontaneous urticaria and COVID-19. Dermatol Ther 2021; 34(6): e15111.
- 3. Erdem Y, Polat Ekinci A, Altunay IK, Sivaz O, Inal S, Gokalp MO, et al. The impact of COVID-19 pandemic on the management of patients with chronic urticaria: An observational two-center study from Turkey. Dermatol Ther 2021; 34(1): e14652.
- 4. Klimek L, Pfaar O, Worm M, Eiwegger T, Hagemann J, Ollert M, et al. Use of biologicals in allergic and type-2 inflammatory diseases during the current COVID-19 pandemic: Position paper of Ärzteverband Deutscher Allergologen (AeDA)A, Deutsche Gesellschaft für Allergologie und Klinische Immunologie (DGAKI)B, Gesellschaft für Pädiatrische Allergologie und Umweltmedizin (GPA)C, Österreichische Gesellschaft für Allergologie und Immunologie (ÖGAI)D, Luxemburgische Gesellschaft für Allergologie und Immunologie (LGAI)E, Österreichische Gesellschaft für Pneumologie (ÖGP)F in co-operation with the German, Austrian, and Swiss ARIA groupsG, and the European Academy of Allergy and Clinical Immunology (EAACI)H. Allergol Select 2020; 4: 53–68.
- 5. Gill MA, Liu AH, Calatroni A, Krouse RZ, Shao B, Schiltz A, et al. Enhanced plasmacytoid dendritic cell antiviral responses after omalizumab. J Allergy Clin Immunol 2018; 141(5): 1735–43.e9.
| APA | Özdemir Ö, Dikici Ü (2022). Incidence of SARS-CoV-2 Infection in Asthma Patients on Omalizumab Therapy. , 533 - 534. 10.14744/etd.2022.28938 |
| Chicago | Özdemir Öner,Dikici Ümmügülsüm Incidence of SARS-CoV-2 Infection in Asthma Patients on Omalizumab Therapy. (2022): 533 - 534. 10.14744/etd.2022.28938 |
| MLA | Özdemir Öner,Dikici Ümmügülsüm Incidence of SARS-CoV-2 Infection in Asthma Patients on Omalizumab Therapy. , 2022, ss.533 - 534. 10.14744/etd.2022.28938 |
| AMA | Özdemir Ö,Dikici Ü Incidence of SARS-CoV-2 Infection in Asthma Patients on Omalizumab Therapy. . 2022; 533 - 534. 10.14744/etd.2022.28938 |
| Vancouver | Özdemir Ö,Dikici Ü Incidence of SARS-CoV-2 Infection in Asthma Patients on Omalizumab Therapy. . 2022; 533 - 534. 10.14744/etd.2022.28938 |
| IEEE | Özdemir Ö,Dikici Ü "Incidence of SARS-CoV-2 Infection in Asthma Patients on Omalizumab Therapy." , ss.533 - 534, 2022. 10.14744/etd.2022.28938 |
| ISNAD | Özdemir, Öner - Dikici, Ümmügülsüm. "Incidence of SARS-CoV-2 Infection in Asthma Patients on Omalizumab Therapy". (2022), 533-534. https://doi.org/10.14744/etd.2022.28938 |
| APA | Özdemir Ö, Dikici Ü (2022). Incidence of SARS-CoV-2 Infection in Asthma Patients on Omalizumab Therapy. Erciyes Medical Journal, 44(5), 533 - 534. 10.14744/etd.2022.28938 |
| Chicago | Özdemir Öner,Dikici Ümmügülsüm Incidence of SARS-CoV-2 Infection in Asthma Patients on Omalizumab Therapy. Erciyes Medical Journal 44, no.5 (2022): 533 - 534. 10.14744/etd.2022.28938 |
| MLA | Özdemir Öner,Dikici Ümmügülsüm Incidence of SARS-CoV-2 Infection in Asthma Patients on Omalizumab Therapy. Erciyes Medical Journal, vol.44, no.5, 2022, ss.533 - 534. 10.14744/etd.2022.28938 |
| AMA | Özdemir Ö,Dikici Ü Incidence of SARS-CoV-2 Infection in Asthma Patients on Omalizumab Therapy. Erciyes Medical Journal. 2022; 44(5): 533 - 534. 10.14744/etd.2022.28938 |
| Vancouver | Özdemir Ö,Dikici Ü Incidence of SARS-CoV-2 Infection in Asthma Patients on Omalizumab Therapy. Erciyes Medical Journal. 2022; 44(5): 533 - 534. 10.14744/etd.2022.28938 |
| IEEE | Özdemir Ö,Dikici Ü "Incidence of SARS-CoV-2 Infection in Asthma Patients on Omalizumab Therapy." Erciyes Medical Journal, 44, ss.533 - 534, 2022. 10.14744/etd.2022.28938 |
| ISNAD | Özdemir, Öner - Dikici, Ümmügülsüm. "Incidence of SARS-CoV-2 Infection in Asthma Patients on Omalizumab Therapy". Erciyes Medical Journal 44/5 (2022), 533-534. https://doi.org/10.14744/etd.2022.28938 |
